<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-34551" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Breast Magnetic Resonance Imaging</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gunduru</surname>
            <given-names>Mounika</given-names>
          </name>
          <aff>Wayne State University / Detroit Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Grigorian</surname>
            <given-names>Cheryl</given-names>
          </name>
          <aff>Harper Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mounika Gunduru declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Cheryl Grigorian declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-34551.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Over the past several years, magnetic resonance imaging of the breast has become an increasingly important modality for screening for and diagnosing breast cancer. This activity reviews the indications, contraindications, and technique involved in performing magnetic resonance imaging of the breast and highlights the role of the interprofessional team in the care of patients undergoing this imaging modality.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the screening indications for magnetic resonance imaging of the breast.</p></list-item><list-item><p>Review the diagnostic indications for magnetic resonance imaging of the breast.</p></list-item><list-item><p>Outline the technique involved in performing magnetic resonance imaging of the breast.</p></list-item><list-item><p>Explain the importance of improving coordination amongst the interprofessional team to enhance care for patients undergoing magnetic resonance imaging of the breast.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=34551&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=34551">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-34551.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Magnetic resonance imaging (MRI) has come to light as a valuable tool&#x000a0;in breast imaging. It is an ultimate supplementary imaging modality in addition to mammography and ultrasonography in the evaluation of breast disease. Breast MRI is most commonly obtained to evaluate and characterize malignancy. Screening breast MRI has shown higher sensitivity rates in the detection of breast cancer compared&#x000a0;to mammography, ultrasonography or both combined in asymptomatic high-risk women.<xref ref-type="bibr" rid="article-34551.r1">[1]</xref>&#x000a0;The purpose of screening is to find smaller and node-negative cancers, which&#x000a0;reduces breast cancer-specific mortality.<xref ref-type="bibr" rid="article-34551.r1">[1]</xref>&#x000a0;This article aims to review the&#x000a0;indications for screening and diagnostic&#x000a0;breast MRI, discuss&#x000a0;the technique&#x000a0;and some of the most commonly encountered artifacts.</p>
      </sec>
      <sec id="article-34551.s3" sec-type="Indications">
        <title>Indications</title>
        <p>The most common indication for obtaining breast MRI in clinical practice is to evaluate for breast cancer. Studies have shown increased sensitivity in diagnosing breast cancer when MRI supplements mammography in comparison with mammography alone or combined mammography and ultrasonography.<xref ref-type="bibr" rid="article-34551.r2">[2]</xref>&#x000a0;Annual screening MRI of the breasts is&#x000a0;recommended&#x000a0;in high-risk women such as<xref ref-type="bibr" rid="article-34551.r1">[1]</xref><xref ref-type="bibr" rid="article-34551.r2">[2]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Those with the&#x000a0;lifetime risk of 20% or greater</p>
          </list-item>
          <list-item>
            <p>BRCA mutation carriers</p>
          </list-item>
          <list-item>
            <p>Untested first degree relative of BRCA carrier</p>
          </list-item>
          <list-item>
            <p>History of chest irradiation between ages 10 and 30 years.</p>
          </list-item>
          <list-item>
            <p>Women with genetic syndromes predisposing for breast cancer&#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <p>In patients already diagnosed with breast cancer, MR imaging is crucial for further evaluation including<xref ref-type="bibr" rid="article-34551.r2">[2]</xref><xref ref-type="bibr" rid="article-34551.r3">[3]</xref><xref ref-type="bibr" rid="article-34551.r4">[4]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Preoperative assessment of the extent of cancer in newly diagnosed patients for surgical&#x000a0;planning</p>
          </list-item>
          <list-item>
            <p>Screening of contralateral breast in conditions where there is an increased risk of bilaterality such as lobular carcinoma</p>
          </list-item>
          <list-item>
            <p>Breast cancer staging&#x000a0;for treatment planning</p>
          </list-item>
          <list-item>
            <p>Monitoring tumor response to neoadjuvant therapy such as chemotherapy or hormonal therapy</p>
          </list-item>
        </list>
        <p>Preoperative assessment for multifocal and multicentric lesions is important for appropriate treatment, which can decrease&#x000a0;re-excision rate and recurrence rate.</p>
        <p>Other indications for breast MRI include<xref ref-type="bibr" rid="article-34551.r2">[2]</xref><xref ref-type="bibr" rid="article-34551.r3">[3]</xref><xref ref-type="bibr" rid="article-34551.r4">[4]</xref><xref ref-type="bibr" rid="article-34551.r5">[5]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Women with dense breasts, as they have one to two-fold increased risk of breast cancer than the general&#x000a0;population&#x000a0;</p>
          </list-item>
          <list-item>
            <p>To differentiate&#x000a0;scar versus recurrence</p>
          </list-item>
          <list-item>
            <p>Woman with suspected inflammatory breast cancer - MRI demonstrates skin enhancement</p>
          </list-item>
          <list-item>
            <p>Axillary nodal metastasis with unknown primary or occult breast lesion&#x000a0;on mammography and ultrasound</p>
          </list-item>
          <list-item>
            <p>To assess the stability of silicone breast implants</p>
          </list-item>
          <list-item>
            <p>Patients with nipple discharge with inconclusive findings on other imaging studies</p>
          </list-item>
        </list>
        <p>Brown et al. conducted an online survey among primary care providers (PCP) and specialists regarding the frequency of ordering breast MRI which showed that the specialists order more breast MRI studies compared to PCPs.<xref ref-type="bibr" rid="article-34551.r5">[5]</xref> The most common indications for ordering breast MRI in the survey were to evaluate clinical finding with negative mammogram and ultrasound, new breast cancer diagnosis, cancer staging, and monitor response to chemotherapy. To improve and maintain the credibility of MRI in breast imaging, American College of Radiology (ACR) has formulated appropriateness criteria to&#x000a0;provide&#x000a0;the ordering physicians&#x000a0;with appropriate diagnostic imaging studies for their patients.<xref ref-type="bibr" rid="article-34551.r6">[6]</xref></p>
        <p>Some challenges that present with the use of breast MRI include high cost, lack of availability in some of the breast centers, longer examination time, need for intravenous contrast medium, and&#x000a0;false positive reads.<xref ref-type="bibr" rid="article-34551.r5">[5]</xref><xref ref-type="bibr" rid="article-34551.r2">[2]</xref>&#x000a0;False positives result in additional imaging, biopsy, or unnecessary surgical interventions.</p>
      </sec>
      <sec id="article-34551.s4" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>A 1.5 Tesla magnet is widely used for breast imaging.<xref ref-type="bibr" rid="article-34551.r7">[7]</xref>&#x000a0;The patient would be in a prone position. A specialized breast coil is utilized to obtain images.&#x000a0;Intravenous administration of contrast medium such as gadolinium (0.1 mmol/kg) is required in almost all instances, with the exception&#x000a0;of the evaluation of silicone implants. Both breasts are imaged routinely&#x000a0;to assess for symmetry and background parenchymal enhancement. MRI of the breasts should ideally be performed during days 7 to 14 of the menstrual cycle to minimize the effect of hormones on background parenchymal enhancement and to reduce the rate of false positives.<xref ref-type="bibr" rid="article-34551.r2">[2]</xref>&#x000a0;The field of view (FOV) should be carefully selected to ensure adequate anatomical coverage of the region of interest while maintaining spatial resolution. Ideal FOV extends from the clavicle to the infra-mammary fold, including axilla.<xref ref-type="bibr" rid="article-34551.r7">[7]</xref> The interactions of protons in tissue primarily create MR images. The difference in the tissue characteristics of&#x000a0;diseased breast parenchyma in comparison to adjacent normal breast tissue creates signal changes on MR images. Homogenous fat suppression is another vital requirement for cancer detection. Inadequate fat suppression or field inhomogeneity can render the images uninterpretable for subtle lesions.&#x000a0; &#x000a0;</p>
        <p>Breast cancer is the most common indication for obtaining MRI. Dynamic contrast-enhanced&#x000a0;MRI is required to distinguish benign versus malignant lesions of the breast. It enables assessment of tumor morphology and enhancement kinetics.<xref ref-type="bibr" rid="article-34551.r3">[3]</xref>&#x000a0;T1 weighted sequences with fat suppression are most commonly used to obtain contrast-enhanced images.&#x000a0;Malignant lesions are usually larger in size, have&#x000a0;spiculated&#x000a0;or irregular margins and shape with heterogeneous enhancement. Round or oval mass with circumscribed margins, dark septa, and&#x000a0;homogenous enhancement indicate benign lesion. Three different types of kinetic curves exist. Most of the times, malignant&#x000a0;lesions demonstrate rapid uptake with rapid washout of the contrast medium (type III) due to their high vascularity. Benign lesions demonstrate slow,&#x000a0;continuous uptake (type I). Rapid uptake followed by a plateau or persistent enhancement can represent either benign or malignant lesion (type II).<xref ref-type="bibr" rid="article-34551.r3">[3]</xref>&#x000a0;However, in some instances malignant lesions can show slow, persistent uptake and benign lesions can have malignant-type enhancement pattern. Therefore, enhancement patterns and washout curves must always be supplemented with morphologic features of the lesion.<xref ref-type="bibr" rid="article-34551.r2">[2]</xref><xref ref-type="bibr" rid="article-34551.r3">[3]</xref></p>
        <p>Abbreviated MRI protocols have been proposed for cancer screening and diagnosis&#x000a0;with reduced scan time and cost.<xref ref-type="bibr" rid="article-34551.r3">[3]</xref>&#x000a0;New established MRI techniques have been reported in the literature such as diffusion-weighted imaging and proton MR spectroscopy imaging.<xref ref-type="bibr" rid="article-34551.r3">[3]</xref><xref ref-type="bibr" rid="article-34551.r4">[4]</xref>&#x000a0;Additional newer techniques&#x000a0;such as&#x000a0;blood oxygen level&#x000a0;dependent (BOLD) and hyperpolarised MRI are still under investigation.<xref ref-type="bibr" rid="article-34551.r3">[3]</xref>&#x000a0;These newer techniques&#x000a0;are expected to improve the accuracy and specificity of breast MRI.&#x000a0;</p>
        <p>
<bold>Artifacts&#x000a0;</bold>
</p>
        <p>An artifact occurs due to misinterpretation of the object in the FOV.<xref ref-type="bibr" rid="article-34551.r7">[7]</xref>&#x000a0;A well-trained MRI technologist is necessary to obtain good quality MR images. The interpreting radiologists must be aware of these artifacts to&#x000a0;resolve them and improve the image quality.&#x000a0; The following briefly discusses some of the most commonly encountered artifacts in breast imaging.</p>
        <p>Artifacts are broadly classified based on patient factors and technical factors.<xref ref-type="bibr" rid="article-34551.r7">[7]</xref><xref ref-type="bibr" rid="article-34551.r8">[8]</xref></p>
        <p>Patient factors:</p>
        <p>
<italic toggle="yes">1. Motion artifact</italic>
</p>
        <p>Motion can be physiological due to respiration&#x000a0;and pulsation of the blood vessels or patient movement which can be voluntary or involuntary. Patient motion can affect the entire series of images or sometimes only a few images in a series especially when&#x000a0;it is due to pulsation of blood vessels. Motion artifact always occurs in the phase-encoding direction.<italic toggle="yes">Fix:</italic> Educate the patient about the importance of holding still. Patients with pain or claustrophobia&#x000a0;may need adequate analgesia or sedation.</p>
        <p>
<italic toggle="yes">2. Positioning</italic>
</p>
        <p>Improper positioning of the breasts within the breast coil can result in signal distortion and inhomogeneous fat suppression. Large breasts can get compressed against the coil and produce abnormal signal hyperintensity at the site of contact. <italic toggle="yes">Fix:</italic>&#x000a0;Breasts should be properly placed within the dedicated breast coil. Comfortable positioning of the patient with arms by the side or above the head.</p>
        <p>
<italic toggle="yes">3. Metal artifact</italic>
</p>
        <p>Ferromagnetic (iron, nickel, cobalt) and non-ferromagnetic (titanium) metals have higher magnetic susceptibility. Metallic objects such as biopsy clips, jewelry, skin tattoos, metallic snaps on clothing, deposits from core biopsy needle or electrocautery devices produce field inhomogeneity which presents as signal void along with distortion of the image. MRI of the post-surgical breast for local recurrence remains challenging due to the metal artifact.<italic toggle="yes">Fix:</italic> Thorough examination of the patient with the removal of any metallic objects is required; using a lower field strength scanner such as 1.5 Tesla magnet with a short echo time (TE).</p>
        <p>Technical factors:</p>
        <p>
<italic toggle="yes">1. Zipper artifact</italic>
</p>
        <p>Zipper artifact, also known as radiofrequency interference occurs when there is an external radio-frequency (RF) signal that is not consistent with the phase encoding gradient. The images have a noisy background which manifests as alternating dark and bright bands across the image. The source of the external RF signal can be within the imaging unit or outside such as television, radio, or patient monitoring equipment. The imaging unit has a metal shield called the Faraday cage that normally prevents the external RF signal from entering the unit. Breach in this metal shield result in zipper artifact.<italic toggle="yes">Fix:&#x000a0;</italic>Periodic quality control check of the Faraday cage is necessary. Ensure the door to the scan room is closed correctly.&#x000a0;Use of monitoring equipment that is&#x000a0;MR compatible.&#x000a0;&#x000a0;</p>
        <p>
<italic toggle="yes">2. Wrap-around artifact</italic>
</p>
        <p>When the FOV is smaller than the signal producing tissue, it results in a wrap-around artifact. The signal generated by the tissue outside the FOV gets superimposed on the contralateral side of the image. Wrap-around artifact, also known as aliasing, occurs along the phase-encoding direction.<italic toggle="yes">Fix:</italic> Aliasing can be reduced by increasing the FOV or by phase oversampling. Saturation bands can also be used to suppress the signal from excited tissues outside the FOV.</p>
        <p>3. Chemical shift artifact</p>
        <p>There are two kinds of chemical shift artifact. In the first kind, the differences in the precession frequency of the&#x000a0;protons in water and fat generate an image with bright and dark bands on either side of the tissue. This type always occurs in the frequency encoding direction. The second kind of chemical shift artifact occurs on gradient-echo images, where the water and fat protons move in and out of phase at fixed time points, depending on the strength of the magnet (1.5 T or 3T). As a result, there will be signal void at the fat-fluid interface, which presents as a dark&#x000a0;rim around the tissue.<italic toggle="yes">Fix</italic>: Chemical shift artifact (first kind) can be reduced by increasing the bandwidth per pixel. Use of fat suppression technique, longer TE and changing the frequency encoding direction also can reduce this artifact.</p>
        <p>
<italic toggle="yes">4. Moire fringes or Zebra artifact</italic>
</p>
        <p>Zebra artifact is a combination of wrap-around artifact and field inhomogeneity. It&#x000a0;is seen along the edges with larger FOV as alternating bands of bright and dark signal. It can also occur when a body coil is used instead of the breast coil.<italic toggle="yes">Fix:</italic> Selecting appropriate FOV to reduce aliasing or phase oversampling. Shimming of the magnet to reduce field inhomogeneities.</p>
      </sec>
      <sec id="article-34551.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>It is essential to understand the importance of breast MRI and its indications for screening and diagnostic purposes which aids in timely diagnosis, management, and better patient outcome. Identifying the potential artifacts related to the technique and ways to overcome them will yield good quality images and avoid unnecessary interventions.&#x000a0;</p>
      </sec>
      <sec id="article-34551.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Breast cancer ranks as the most common&#x000a0;malignancy in women. Annual screening mammography is recommended to every woman starting at age 40. MRI of the breast is an ideal complementary imaging study to mammography and ultrasound for the evaluation of breast disease.&#x000a0;The primary care provider and nurse practitioner must be aware of the screening recommendations and indications for breast MRI. The interpreting&#x000a0;radiologists&#x000a0;must be&#x000a0;aware of the commonly&#x000a0;encountered artifacts of breast MRI, to&#x000a0;prevent them and improve the quality of the scan. Dynamic&#x000a0;contrast-enhanced&#x000a0;MRI is the most sensitive non-invasive imaging modality to differentiate benign and malignant breast lesions.&#x000a0;The malignant lesions are small and often&#x000a0;node-negative&#x000a0;when identified&#x000a0;with MRI compared to mammography alone. This diagnostic modality leads to early detection of breast&#x000a0;cancer, better patient management, and outcome. Overall, the mortality&#x000a0;rate for breast cancer has been decreasing due to screening and improved management, which is best accomplished with an interprofessional team approach using the various physician specialties (radiology, oncology, and the PCP) along with the nursing staff and radiology techs.</p>
      </sec>
      <sec id="article-34551.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=34551&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=34551">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/34551/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=34551">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-34551.s8">
        <title>References</title>
        <ref id="article-34551.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niell</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Freer</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Weinfurtner</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Arleo</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Drukteinis</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Screening for Breast Cancer.</article-title>
            <source>Radiol Clin North Am</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>1145</fpage>
            <page-range>1145-1162</page-range>
            <pub-id pub-id-type="pmid">28991557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34551.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holbrook</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Newell</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Magnetic Resonance Imaging of the Breast.</article-title>
            <source>Clin Obstet Gynecol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>394</fpage>
            <page-range>394-402</page-range>
            <pub-id pub-id-type="pmid">26982252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34551.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leithner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wengert</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Helbich</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Thakur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ochoa-Albiztegui</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Pinker</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinical role of breast MRI now and going forward.</article-title>
            <source>Clin Radiol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>73</volume>
            <issue>8</issue>
            <fpage>700</fpage>
            <page-range>700-714</page-range>
            <pub-id pub-id-type="pmid">29229179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34551.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clauser</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Athanasiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prosch</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pinker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dietzel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Helbich</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Fuchsj&#x000e4;ger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Camps-Herrero</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sardanelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Forrai</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baltzer</surname>
                <given-names>PAT</given-names>
              </name>
            </person-group>
            <article-title>A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice.</article-title>
            <source>Eur Radiol</source>
            <year>2018</year>
            <month>May</month>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>1909</fpage>
            <page-range>1909-1918</page-range>
            <pub-id pub-id-type="pmid">29168005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34551.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Brook</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharpe</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Slanetz</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Dialani</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Breast MRI ordering practices in a large health care network.</article-title>
            <source>Breast J</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>262</fpage>
            <page-range>262-268</page-range>
            <pub-id pub-id-type="pmid">30746809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34551.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Expert Panel on Breast Imaging:</collab>
              <name>
                <surname>Mainiero</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Moy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Didwania</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>diFlorio</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Heller</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Holbrook</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lewin</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Lourenco</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Nance</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Niell</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Slanetz</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Stuckey</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Vincoff</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Weinstein</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Yepes</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Newell</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>ACR Appropriateness Criteria<sup>&#x000ae;</sup> Breast Cancer Screening.</article-title>
            <source>J Am Coll Radiol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>11S</issue>
            <fpage>S383</fpage>
            <page-range>S383-S390</page-range>
            <pub-id pub-id-type="pmid">29101979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34551.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anthony</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Friedlander</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mango</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Wynn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Artifacts in Breast Magnetic Resonance Imaging.</article-title>
            <source>Curr Probl Diagn Radiol</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>271</fpage>
            <page-range>271-7</page-range>
            <pub-id pub-id-type="pmid">26343534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34551.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harvey</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hendrick</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Coll</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Nicholson</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Burkholder</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Breast MR imaging artifacts: how to recognize and fix them.</article-title>
            <source>Radiographics</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>27 Suppl 1</volume>
            <fpage>S131</fpage>
            <page-range>S131-45</page-range>
            <pub-id pub-id-type="pmid">18180223</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
